Pharvaris N.V.
PHVS · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Lu Peng: Form 4
Insider disclosure · Filed · Report period 11 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- PHVS · N69605108 - Ordinary shares, par value Euro 0.12 per share
Company details and SEC sources
CIK 0001830487 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- PHVS on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- J.H. Oortweg 21, 2333 Ch Leiden, Leiden
- Incorporated in
- Netherlands
- Fiscal year end
- 31 December
- Former names on EDGAR
- Pharvaris, B.V. (to 04 Feb 2021)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields